tactics/activities to support the launch of CAGSEVY (our 1st hemoglobinopathy gene editing product) across the International..., Hemoglobinopathies (sickle cell disease and beta thalassemia), cell and/or genetic therapy experience is a bonus Required Knowledge...
Lifelancer